Atai Life Sciences (ATAI) Competitors $2.02 +0.11 (+5.76%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$2.02 +0.00 (+0.05%) As of 05/22/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI vs. BGM, AUPH, WVE, GYRE, MLYS, PAHC, COLL, SNDX, ELVN, and RCUSShould you be buying Atai Life Sciences stock or one of its competitors? The main competitors of Atai Life Sciences include Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Mineralys Therapeutics (MLYS), Phibro Animal Health (PAHC), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Enliven Therapeutics (ELVN), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry. Atai Life Sciences vs. Qilian International Holding Group Aurinia Pharmaceuticals Wave Life Sciences Gyre Therapeutics Mineralys Therapeutics Phibro Animal Health Collegium Pharmaceutical Syndax Pharmaceuticals Enliven Therapeutics Arcus Biosciences Qilian International Holding Group (NASDAQ:BGM) and Atai Life Sciences (NASDAQ:ATAI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Do insiders & institutionals have more ownership in BGM or ATAI? 28.4% of Atai Life Sciences shares are owned by institutional investors. 58.7% of Qilian International Holding Group shares are owned by insiders. Comparatively, 31.2% of Atai Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, BGM or ATAI? Qilian International Holding Group has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Atai Life Sciences has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Does the MarketBeat Community believe in BGM or ATAI? Atai Life Sciences received 336 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/AAtai Life SciencesOutperform Votes33666.53% Underperform Votes16933.47% Does the media refer more to BGM or ATAI? In the previous week, Atai Life Sciences had 7 more articles in the media than Qilian International Holding Group. MarketBeat recorded 7 mentions for Atai Life Sciences and 0 mentions for Qilian International Holding Group. Atai Life Sciences' average media sentiment score of 0.64 beat Qilian International Holding Group's score of 0.00 indicating that Atai Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Qilian International Holding Group Neutral Atai Life Sciences Positive Is BGM or ATAI more profitable? Qilian International Holding Group's return on equity of 0.00% beat Atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Atai Life Sciences N/A -65.75%-52.71% Which has preferable earnings & valuation, BGM or ATAI? Qilian International Holding Group has higher revenue and earnings than Atai Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M48.38-$1.44MN/AN/AAtai Life Sciences$1.86M219.91-$40.22M-$0.91-2.25 Do analysts recommend BGM or ATAI? Atai Life Sciences has a consensus target price of $10.50, suggesting a potential upside of 413.45%. Given Atai Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Atai Life Sciences is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Atai Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 SummaryAtai Life Sciences beats Qilian International Holding Group on 9 of the 15 factors compared between the two stocks. Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATAI vs. The Competition Export to ExcelMetricAtai Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$409.69M$6.51B$5.35B$8.44BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-2.529.1526.9119.77Price / Sales219.91259.30390.06119.10Price / CashN/A65.8538.2534.62Price / Book1.396.476.794.52Net Income-$40.22M$144.21M$3.23B$248.23M7 Day Performance25.46%2.64%1.99%0.77%1 Month Performance39.12%4.80%11.45%13.45%1 Year Performance22.46%-2.52%17.35%7.67% Atai Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATAIAtai Life Sciences2.3001 of 5 stars$2.02+5.8%$10.50+419.8%+21.0%$404.68M$1.86M-2.4980News CoverageAnalyst ForecastAnalyst RevisionBGMQilian International Holding GroupN/A$11.54+4.7%N/AN/A$1.12B$25.10M0.00298Positive NewsGap UpAUPHAurinia Pharmaceuticals2.4142 of 5 stars$8.14+1.8%$11.50+41.3%+49.5%$1.12B$235.13M-54.40300WVEWave Life Sciences4.3742 of 5 stars$6.69+1.4%$21.17+216.6%-5.4%$1.03B$108.30M-6.02240Positive NewsGYREGyre Therapeutics0.3745 of 5 stars$11.00+15.4%N/A-17.2%$1.02B$105.76M544.5040News CoverageMLYSMineralys Therapeutics2.884 of 5 stars$15.38+5.0%$33.00+114.5%+30.4%$992.93MN/A-4.2028Analyst UpgradeGap DownPAHCPhibro Animal Health3.52 of 5 stars$24.51+9.1%$20.00-18.4%+25.0%$990.30M$1.11B50.941,860Positive NewsCOLLCollegium Pharmaceutical4.0425 of 5 stars$29.96+3.7%$43.80+46.2%-15.7%$961.71M$631.45M12.90210Positive NewsSNDXSyndax Pharmaceuticals3.8219 of 5 stars$11.08+3.5%$35.91+224.2%-47.9%$954.69M$43.72M-3.06110Positive NewsELVNEnliven Therapeutics2.4734 of 5 stars$19.34+5.0%$40.33+108.5%-26.7%$949.13MN/A-10.1850News CoverageAnalyst RevisionGap UpRCUSArcus Biosciences3.6538 of 5 stars$8.92+7.8%$25.67+187.6%-47.6%$939.73M$141M-2.82500Gap UpHigh Trading Volume Related Companies and Tools Related Companies BGM Competitors AUPH Competitors WVE Competitors GYRE Competitors MLYS Competitors PAHC Competitors COLL Competitors SNDX Competitors ELVN Competitors RCUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATAI) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATAI Stock Free ATAI Stock Alerts